Presentation is loading. Please wait.

Presentation is loading. Please wait.

Supplemental figure 1 ROS production in MM cell line (KMM1) treated with bortezomib and DCA. ROS production was marginally increased by DCA in combination.

Similar presentations


Presentation on theme: "Supplemental figure 1 ROS production in MM cell line (KMM1) treated with bortezomib and DCA. ROS production was marginally increased by DCA in combination."— Presentation transcript:

1 Supplemental figure 1 ROS production in MM cell line (KMM1) treated with bortezomib and DCA. ROS production was marginally increased by DCA in combination with bortezomib. p< p=0.0023

2 Cut off is median (= ) p=0.24 (log rank) (N=27) Cut off is median (= ) (N=27) p=0.84 (log rank) p=0.29 (log rank) Cut off is median (= 9.98) (N=27) p=0.20 (log rank) Cut off is median (= 287) (N=27) Supplemental figure 2 Overall survival analysis of our cohort which was sub-grouped by expression of glycolysis- related genes except LDH. None of these genes serves as prognostic factor in our cohort.

3 LDHA (NM_ ) p=0.031 (Log-rank) PDK1 (NM_ ) p= (Log-rank) PDK1 ( AU ) p= (Log- rank) HIF1A (TT2, NM_ ) p= (Log- rank) GLUT1 (TT2, AI ) p= (Log-rank) GLUT1 (TT2, NM_006516) p= (Log- rank) MYC (TT2, NM_ ) p= (Log- rank) MYC (TT2, BF ) p= (Log- rank) Supplemental figure 3 Overall survival analysis in TT2 cohort (Re-analyzed using data by Zani et al.). Cases were sub- grouped by expression of LDHA, cMYC, GLUT1, HIF1A and PDK1. LDHA was the only prognostic factor.

4 p=0.0016p< p=0.9412p< Kruskal-Wallis test And Dunns multiple Comparison test * Supplemental figure 4 Expression of LDHA, cMYC, GLUT1, HIF1A and PDK1 in the 8 molecular subgroups of MM utilizing database deposited by Zhan et al. All genes except GLUT1 showed significant heterogeneous expressions. *: LDHA expression of CD2 group was significantly lowest than the other groups.

5 p= p=0.2774p=0.0805p= p= p= p=0.9207p= Supplemental figure 5 The association between the expression of LDHA, cMYC, GLUT1, HIF1A and PDK1 in 6 molecular subgroups of human myeloma cell lines utilizing data of Moreaux et al. There was no significant difference in expression of these genes within subgroups.


Download ppt "Supplemental figure 1 ROS production in MM cell line (KMM1) treated with bortezomib and DCA. ROS production was marginally increased by DCA in combination."

Similar presentations


Ads by Google